Navigation Links
Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
Date:4/8/2009

CHERRY HILL, N.J., April 8 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX.OB), formerly eFoodSafety.com, an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products, announced today that it intends to reduce the suggested list price and launch an advertising and promotion campaign for Cinnergen, a cranberry cinnamon liquid supplement that helps promote healthy glucose metabolism, to raise customer awareness and garner increased demand for the product at a lower price point.

Effective May 1, 2009, Nuvilex' wholly owned subsidiary, Cinnergen, Inc., will reduce the suggested retail price for a 32 ounce bottle of Cinnergen to $26.95 from $34.95. Additionally, lower multi-level wholesale pricing will be established to support the Company's retail partners. Tiered wholesale pricing will range from $186 to $162 per twelve-bottle case ($15.50 to $13.50 per 32 ounce bottle). The Company will discontinue production of its 16-ounce bottle size. The Cinnergen product is sold through leading retail establishments, such as AmeriMark, CVS Caremark, GNC, H E Butt Grocery Company, Hi-Health, RiteAid, USA Drug, Vermont Country Store, Virodyne, Vitamin Shoppe and Wal-Mart.

Nuvilex has separately executed a partnership agreement for the promotion of Cinnergen with dLife, the only multimedia network serving the diabetes community. The dLife advertising and promotion campaign is expected to launch in mid April. Its award-winning multimedia outlets include dLife TV, the only lifestyle TV series for people with diabetes, which airs every Sunday on CNBC at 7:00 PM ET/4:00 PM PT. With more than 80,000 pages of superior content, 9,000 diabetic recipes, and 400 videos, dLife.com is the leading online destination for diabetes information, inspiration and connection. The dLife network also includes: dLifeRadio, featuring the dLife Diabetes Minute, which can be
'/>"/>

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
2. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
3. Trista Sutter Announces She Will Get the Essure Permanent Birth Control Procedure
4. Clarity Group, Inc. Announces Launch of New Website
5. ORTHOCON Announces Appointment of New CEO and $25 Million Series B Financing
6. Mylan Announces Clarinex(R) Settlement Agreement
7. Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online
8. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
9. Lincoln Financial Group Announces Family Care Reimbursement Benefit Rider on LTD Policies
10. Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Noncompliance with Nasdaq Audit Committee Composition Requirements
11. UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report 2Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina 2Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 2Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 3Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 4Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 5Health News:INTEGRIS Health Selects Allscripts Care Management for Its 13 Hospitals 6Health News:Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic 2Health News:Health Care Spending in U.S. Grew at Lowest Rate in a Decade 2Health News:Health Care Spending in U.S. Grew at Lowest Rate in a Decade 3Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 2Health News:CVS/pharmacy Offers Shoppers More Than $69 Million in 'Extra Bucks' 3
Breaking Medicine Technology:Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 1Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 2Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 3Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 4ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 2NewCardio Completes 242 9 Million Private Placement 57625 1NewCardio Completes 242 9 Million Private Placement 57625 2NewCardio Completes 242 9 Million Private Placement 57625 3NewCardio Completes 242 9 Million Private Placement 57625 4